pramipexole has been researched along with Nausea in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Keränen, T; Kuusisto, H; Tuhkasaari, M | 1 |
Aiken, CB | 1 |
Culhane, M; Evins, AE; Frank, MJ; Pajtas, PE; Pizzagalli, DA; Santesso, DL; Schetter, EC | 1 |
Hanna, PA; Jankovic, J; Ondo, WG; Ratkos, L | 1 |
1 review(s) available for pramipexole and Nausea
Article | Year |
---|---|
Pramipexole in psychiatry: a systematic review of the literature.
Topics: Animals; Antiparkinson Agents; Benzothiazoles; Bipolar Disorder; Compulsive Behavior; Depressive Disorder; Dopamine Agonists; Drug Interactions; Drug Resistance; Headache; Humans; Nausea; Parkinson Disease; Pramipexole; Psychoses, Substance-Induced; Sleep Wake Disorders | 2007 |
2 trial(s) available for pramipexole and Nausea
Article | Year |
---|---|
Single dose of a dopamine agonist impairs reinforcement learning in humans: behavioral evidence from a laboratory-based measure of reward responsiveness.
Topics: Administration, Oral; Adult; Age Factors; Algorithms; Association Learning; Behavior; Benzothiazoles; Blood Pressure; Chi-Square Distribution; Discrimination Learning; Dizziness; Double-Blind Method; Female; Humans; Male; Nausea; Pramipexole; Reaction Time; Receptors, Dopamine D2; Receptors, Dopamine D3; Reinforcement Schedule; Reward; Sex Factors | 2008 |
Switching from pergolide to pramipexole in patients with Parkinson's disease.
Topics: Accidental Falls; Aged; Aged, 80 and over; Benzothiazoles; Dopamine Agonists; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Edema; Female; Hallucinations; Humans; Male; Middle Aged; Nausea; Parkinson Disease; Pergolide; Pramipexole; Prospective Studies; Receptors, Dopamine; Sweating; Thiazoles; Treatment Outcome | 2001 |
1 other study(ies) available for pramipexole and Nausea
Article | Year |
---|---|
Long-term retention rate of pramipexole in the treatment of Parkinson's disease.
Topics: Antiparkinson Agents; Benzothiazoles; Confusion; Dopamine Agonists; Finland; Hallucinations; Humans; Medication Adherence; Nausea; Netherlands; Parkinson Disease; Pramipexole; Retrospective Studies; Risk Factors | 2009 |